Table 2.
South-East Asia n = 23 |
Europe and Central Asia n = 25 |
Middle East and North Africa n = 23 |
Latin America and Caribbean n = 39 |
Sub-Saharan Africa n = 35 |
|
---|---|---|---|---|---|
Guidelines followed or in usea | |||||
WHO | 10 (43%) | 14 (56%) | 16 (70%) | 14 (36%) | 15 (43%) |
National | 17 (74%) | 19 (76%) | 8 (35%) | 19 (49%) | 19 (54%) |
Local | 11 (48%) | 7 (28%) | 8 (35%) | 27 (69%) | 16 (46%) |
Viral testing | |||||
Not available | 3 (13%) | 2 (8%) | 4 (17%) | 2 (5%) | 6 (17%) |
Available, intermittent access | 6 (26%) | 4 (16%) | 10 (43%) | 16 (41%) | 18 (51%) |
Available, no restrictions | 14 (61%) | 19 (76%) | 9 (40%) | 21 (54%) | 11 (32%) |
Delivery room management | |||||
Immediate cord clamping | 11 (48%) | 15 (60%) | 8 (35%) | 19 (49%) | 7 (20%) |
Delayed cord clamping | 4 (17%) | 7 (28%) | 3 (13%) | 17 (44%) | 12 (34%) |
Do not know/missing | 8 (35%) | 3 (12%) | 12 (52%) | 3 (7%) | 16 (46%) |
Separate asymptomatic infant from mother with COVID-19 | 6 (26%) | 14 (56%) | 11 (47%) | 15 (38%) | 7 (20%) |
Feeding of asymptomatic infant born to mother with COVID-19 | |||||
Breastfeeding | 14 (61%) | 12 (48%) | 10 (43%) | 19 (49%) | 21 (60%) |
Expressed breast milk | 5 (22%) | 8 (32%) | 7 (30%) | 16 (41%) | 9 (26%) |
Formula | 3 (13%) | 5 (20%) | 6 (26%) | 3 (8%) | 2 (6%) |
Do not know | 1 (4%) | 0 | 0 | 1 (3%) | 3 (9%) |
Discharge of asymptomatic infant born to mother with COVID-19 | |||||
As before | 11 (48%) | 4 (16%) | 6 (26%) | 25 (64%) | 15 (43%) |
Later (for observation) | 6 (26%) | 9 (36%) | 5 (22%) | 3 (8%) | 10 (29%) |
Earlier (to avoid transmission) | 2 (9%) | 7 (28%) | 9 (39%) | 10 (20%) | 5 (14%) |
Do not know | 4 (17%) | 5 (20%) | 3 (13%) | 1 (3%) | 5 (14%) |
aMultiple responses possible. Total may exceed 100% for this item.